Full text is available at the source.
Abstract
Bofanglutide is a novel glucagon-like peptide-1 receptor agonist under development for type 2 diabetes mellitus (T2DM) and overweight and obesity.
- Bofanglutide may help regulate blood sugar levels in individuals with T2DM.
- This medication could assist in weight management for people with obesity.
- It is associated with the potential for improved metabolic health in overweight individuals.
Simplified